Cloud Computing Adoption In The APAC Life Sciences Industry
Introduction
This analysis pack looks at the issues of cloud computing adoption within the pharmaceuticals and bio-tech industries of Japan, China, and India. It is based upon a survey conducted in the second half of 2009 with the results published in November 2009 and looks at the propensity to adopt cloud computing.
Scope
*Evaluates the responses of a total of 50 life sciences companies from India, China, and Japan.
*Discusses which types of companies are more likely to invest in cloud computing solutions, based on key demographic and IT information.
*Provides actionable recommendations for technology vendors looking to offer cloud computing solutions.
Highlights
Delivering new functionality to business users is the highest priority for those pharmaceutical companies looking to invest in cloud computing. This bodes well for SaaS in particular as IT departments look to quickly deploy business process-centric functionality via solutions such as CRM.
Reasons to Purchase
*Gain insight into the cloud computing investment plans for a total of 50 life sciences companies in Japan, China, and India.
*Understand Ovum's opinion on how best to engage with life sciences companies for cloud computing solutions.
More Research Reports
- Electronic health records: getting it right first time
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Stakeholder Opinions: Ophthalmology - Leading brands under threat
- Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
- Healthcare Regulatory Update: The United Arab Emirates
- Point of Care Testing: Evaluating the return to evidence based medicine, novel technologies and the competitive landscape
- Pipeline and Commercial Insight: Supportive Care in Oncology
- Mapping the Healthcare Landscape Bringing pharmaceuticals into focus
- The Gastrointestinal Market Outlook To 2014: Market dynamics, competitive landscape, emerging therapies
